Niva Bupa Health Insurance Company Ltd (NIVABUPA) — shareholding pattern, promoter holding, financials and share price
About Niva Bupa Health Insurance Company Ltd (NIVABUPA)
Niva Bupa Health Insurance Company Ltd operates in the General Insurance industry, within the Financial Services sector. It trades on the NSE as NIVABUPA and on the BSE under scrip code 544286. Its ISIN is INE995S01015.
Incorporated in 2008, Niva Bupa Health Insurance Ltd is a Tech driven leading health insurer in India. [1]
Niva Bupa Health Insurance Company Limited is a standalone health insurer focusing on the retail health market. It underwrites health insurance, personal accident, critical illness, and travel insurance products in India. The company is a joint venture between Bupa Singapore Holdings and Fettle Tone LLP.
In 9M'FY2026, Niva Bupa reported a Gross Written Premium (GWP) of ₹6,309 crore, up 25.9% year-on-year. Profit after tax for the same period stood at ₹208 crore, reflecting a robust growth of 74.3% over the previous year.
Listed peers in General Insurance: Star Health & Allied Insurance Company Ltd, New India Assurance Company Ltd, Go Digit General Insurance Ltd, Canara HSBC Life Insurance Company Ltd, Turtlemint Fintech Solutions Ltd, Medi Assist Healthcare Services Ltd.
Valuation & Returns
10 Jul 2026At ₹86.66 a share on 10 Jul 2026, Niva Bupa Health Insurance Company Ltd (NIVABUPA) was valued at a price-to-earnings ratio of 122.54x against an industry P/E of 15.61x and a price-to-book of 4.24x on a book value of ₹20.42 per share as of Mar 2025. Solomo computes return on equity of 3.46% and return on capital employed of 3.15% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 122.54x
- Industry P/E
- 15.61x
- P/B
- 4.24x
- EPS (TTM)
- ₹0.71
- Book value / share
- ₹20.42
- ROE
- 3.46%
- ROCE
- 3.15%
- ROA
- 1.34%
- Debt / equity
- 0.07x
- Dividend yield
- 0%
- EBITDA margin
- 2.09%
- 52-week range
- ₹67.5 – ₹92.93
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Niva Bupa Health Insurance Company Ltd (NIVABUPA) reported revenue of ₹6,695 crore, net profit of ₹131 crore and earnings per share of ₹0.71. That compares with revenue of ₹5,374 crore and net profit of ₹214 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹2,139 crore and net profit ₹345 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 1,877 | 2,853 | 4,115 | 5,374 | 6,695 |
| Net profit (₹ cr) | -197 | 13 | 82 | 214 | 131 |
| EPS (₹) | - | - | -0.53 | 1.17 | 0.71 |
| Measure | 3Y | 1Y |
|---|---|---|
| Sales growth | 36.06% | 30.59% |
| Profit growth | - | 160.87% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 55.3% of Niva Bupa Health Insurance Company Ltd (NIVABUPA) (down 0.06 pp QoQ), foreign institutional investors (FII) hold 12.09% and domestic institutional investors (DII) hold 16.17%. Market capitalisation was ₹16,025 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Dec 2024.
Largest disclosed public shareholders in Jun 2026: FETTLE TONE LLP 7.18%, Nippon India Mutual Fund Through various schemes 3.11%, INDIA BUSINESS EXCELLENCE FUND IV 2.62%, V-SCIENCES INVESTMENTS PTE LTD 2.42%, AMANSA HOLDINGS PRIVATE LIMITED 2.29%, A91 EMERGING FUND II LLP 2.11%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 55.3% | - | 12.09% | 16.17% | 44.7% |
| Mar 2026 | 55.36% | - | 10.6% | 16.49% | 44.64% |
| Dec 2025 | 55.36% | - | 10.32% | 16.04% | 44.64% |
| Sep 2025 | 55.41% | - | 10.72% | 15.31% | 44.59% |
| Jun 2025 | 55.43% | - | 10.76% | 15.06% | 44.57% |
| Mar 2025 | 55.98% | - | 8.9% | 9.7% | 44.02% |
| Dec 2024 | 55.98% | - | 8.85% | 9.83% | 44.02% |